Tennessee HB 2335: Controlled Substances - As enacted, prohibits a healthcare provider who is authorized to prescribe buprenorphine under federal law from prescribing via telehealth a buprenorphine product, as approved by the federal food and drug administration for use in recovery or medication-assisted treatment, unless certain conditions met. - Amends TCA Title 33; Title 53; Title 63 and Title 68.

Status: Pub. Ch. 881 (as of 2022-04-26)

State: Tennessee · Session: 112 · Bill: HB 2335

Subjects: Controlled Substances

Sponsors: Haile, Vaughan

View Tennessee HB 2335 on LegisTrack → — full text, sponsors, votes, campaign finance, and cross-state matches.